Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | AZN | AMGN | GILD | VRTX |
| Company | Rapport Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 30.67 | 90.37 | 321.21 | 122.00 | 454.28 |
| High | 30.86 | 91.31 | 324.00 | 122.98 | 454.62 |
| Low | 29.64 | 90.12 | 319.06 | 120.06 | 449.48 |
| Latest | 29.94 | 91.17 | 322.52 | 120.80 | 451.78 |
| Change | -0.33 | +1.34 | +4.78 | +1.19 | -0.26 |
| % Change | -1.09% | +1.49% | +1.50% | +0.99% | -0.06% |
| Volume | 78,255 | 3,158,123 | 1,152,024 | 2,459,414 | 498,135 |
| 20-Day Average Volume | 358,910 | 5,636,456 | 2,746,611 | 6,839,992 | 1,350,422 |
| Previous Close | 30.27 | 89.83 | 317.74 | 119.61 | 452.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.28 | 90.70 | 333.19 | 123.99 | 438.31 |
| 20-Day Raw Stochastic | 87.17% | 47.81% | 21.49% | 16.84% | 70.90% |
| 20-Day Relative Strength | 58.90 | 58.36 | 49.02 | 47.33 | 58.59 |
| Weighted Alpha | +28.57 | +41.75 | +20.55 | +26.77 | +12.29 |
| Today's Opinion | 100% Buy | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | 56% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.30% since 12/08/25 | -0.21% since 12/08/25 | -0.48% since 12/08/25 | -0.61% since 12/08/25 | +1.95% since 12/08/25 |
| Low | 27.81 on 12/10/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 31.00 on 12/09/25 | 91.66 on 12/10/25 | 324.00 on 12/15/25 | 123.74 on 12/11/25 | 456.00 on 12/12/25 |
| 1-Month | |||||
| %Chg | +23.39% since 11/14/25 | +2.23% since 11/14/25 | -5.06% since 11/14/25 | -3.66% since 11/14/25 | +3.09% since 11/14/25 |
| Low | 23.75 on 11/17/25 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 31.00 on 12/09/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +21.59% since 09/15/25 | +16.71% since 09/15/25 | +16.51% since 09/15/25 | +7.03% since 09/15/25 | +14.61% since 09/15/25 |
| Low | 23.75 on 11/17/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 31.00 on 12/09/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +168.72% since 06/13/25 | +22.40% since 06/13/25 | +8.29% since 06/13/25 | +9.52% since 06/13/25 | -1.05% since 06/13/25 |
| Low | 10.51 on 06/23/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 42.27 on 09/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,442,698 | 278,601,088 | 171,096,960 | 149,377,888 | 114,691,136 |
| Shares Outstanding, K | 47,661 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -78,310,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -26,930,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.63 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/10/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.76 | 14.51 | 15.04 | 29.13 |